Sorrento SRNE has 33.2% of float short. It ran from 2 to 20 last year and from 7 to 17 this month, now under 13. Hindenburg got involved in shorting after CEO was on Mad Money. They have a large Covid portfolio. Waiting for EUA For rapid test. They also have antibody nose drops for right after exposure and stem cells for ICU patients on oxygen. 1st 3 treated with stem cells were discharged within a week. Analyst Riley gave 26 price target today. Sorrento owns 25% of Cellularity which is doing a SPAC soon with GXGX Also they are suing the richest MD in the world who owns LA Times - he bought rights to a cancer drug and then killed it so his other drug would sell more. SRNE will settle soon for $1 billion.
Anyway, check it out. Active board on iHub Thanks Steve for the invitation. I love your casinos
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.